News
SAVE THE DATE! Ansys-FDA-Avicenna event in Washington on 11 October 2019
Innovation through healthcare simulationFor those of you who will be in Washington mid-October, ANSYS, in cooperation with the FDA and the Avicenna Alliance, is organizing a roundtable discussion titled "Transforming Computational Modeling from A Valuable Scientific Tool to A Valuable Regulatory Tool: Myth or Reality?"
Avicenna answers online consultation to shape Horizon Europe
On 23 July the Avicenna Alliance has submitted its opinion to on the strategic priorities of Horizon Europe, the EU’s next framework programme for research and innovation (R&I). The Commission had indeed launched an online consultation addressed to individuals and organisations with an interest in the future EU R&I priorities.
Prestigious FDA award allocated to group that developed the V&V 40 standard
The Avicenna Alliance is proud to announce that some of its working group members have received the FDA Crosscutting Group Honor Award on 2 August 2019.
Dassault Systèmes signs Research Agreement with the FDA
Dassault Systèmes and the U.S. Food and Drug Administration have concluded a five-year extension of their collaboration on the 3DEXPERIENCE platform in order to develop a new digital tool to enable more efficient regulatory review of cardiovascular and medical devices.
European Commission launches tender for studies on AI and E-Health
On 7 August, the European Commission launched a tender for two studies to survey and analyse progress on the digital transformation of the health and care in the EU.
Commission launches call for proposals to develop AI Excellence Centres
On 12 July, the European Commission has launched a call for proposals to develop a European network of artificial intelligence (AI) centres. Proposals for the call may be submitted up till 13 November 2019.
